BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15848736)

  • 1. Molecular genetics of familial renal cell carcinoma syndromes.
    Cohen D; Zhou M
    Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic basis of cancer of the kidney.
    Linehan WM; Walther MM; Zbar B
    J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations and histopathologic findings in familial renal cell carcinoma.
    Hansel DE
    Histol Histopathol; 2006 Apr; 21(4):437-44. PubMed ID: 16437389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical aspects of familial renal neoplasms.
    Iliopoulos O; Eng C
    Semin Oncol; 2000 Apr; 27(2):138-49. PubMed ID: 10768593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
    Linehan WM; Vasselli J; Srinivasan R; Walther MM; Merino M; Choyke P; Vocke C; Schmidt L; Isaacs JS; Glenn G; Toro J; Zbar B; Bottaro D; Neckers L
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6282S-9S. PubMed ID: 15448018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of hereditary renal cancer syndromes: a pending issue for oncologists.
    García-Donas J; Hernando S; Romero N; Jara C
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S15-20. PubMed ID: 21173603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic disorders and renal cell carcinoma.
    Maranchie JK; Linehan WM
    Urol Clin North Am; 2003 Feb; 30(1):133-41. PubMed ID: 12580565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial adult renal neoplasia.
    Takahashi M; Kahnoski R; Gross D; Nicol D; Teh BT
    J Med Genet; 2002 Jan; 39(1):1-5. PubMed ID: 11826016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Renal Cancer Syndromes.
    Yanus GA; Kuligina ES; Imyanitov EN
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.
    Pfaffenroth EC; Linehan WM
    Expert Opin Biol Ther; 2008 Jun; 8(6):779-90. PubMed ID: 18476789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial non-syndromic clear cell renal cell carcinoma.
    Woodward ER
    Curr Mol Med; 2004 Dec; 4(8):843-8. PubMed ID: 15579031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
    Petrella BL; Lohi J; Brinckerhoff CE
    Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic backgrounds of renal cell carcinoma].
    Oya M
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():593-6. PubMed ID: 16523961
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
    Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
    Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary kidney cancer syndromes.
    Haas NB; Nathanson KL
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):81-90. PubMed ID: 24359990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.